To cite this paper use one of the standards below:
Characterising sequential biomarker changes against clinical progression in prodromal prion disease can provide insights vital for early diagnosis, and influence design of primary prevention studies. We sought to leverage diverse longitudinal biomarkers and natural history data from the UK National Prion Monitoring Cohort to facilitate individual-level estimates of proximity to clinical disease onset.
We followed 27 asymptomatic PRNP mutation carriers annually to clinical onset, with deep clinical profiling, neuropsychological, neurophysiological, and fluid biomarker indices. Carriers were segregated according to mutation-dependent disease durations: very slow (OPRIs), slow (P102L/A117V/T107I) and fast (E200K/D178N). Data were modelled using piecewise linear regression (covariates: age, sex) with time of slope change-points (p < 0.05) reported.
Our results identified distinct rates and sequences of changes in clinical and biological markers relative to clinical onset (time 0) for each group – clinical symptoms, neuropsychology and plasma biomarkers between 4-6 years before onset in the very slow group; neurophysiology, clinical symptoms and plasma biomarkers 3-4 years before onset in the slow group; neuropsychology, fluid biomarkers, and clinical symptoms within 1 year before onset in the fast group.
Prodromal symptomatology and biomarker trends appear to have a duration mirroring disease duration. Multimodal modelling of biomarker trajectories show promise in stratifying individuals’ proximity to clinical disease onset, crucial for design of, and early recruitment to primary prevention clinical trials.
Funding information: the NPMC is funded by the UCLH Trust NIHR Biomedical Research Centre, LHM receives funding from an MRC CRTF
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper